Effectiveness of Aligners Versus Rapid Maxillary Expansion
Launched by UNIVERSITY OF TURIN, ITALY · Feb 14, 2021
Trial Information
Current as of May 06, 2025
Completed
Keywords
ClinConnect Summary
Aim of the study is to assess the effectiveness of Invisalign® First clear aligners compared to tooth-borne Hyrax-type maxillary expander on palatal morphology in growing subjects using 3D technology. This two-arm parallel-group randomized prospective clinical trial will include patients with: indications for maxillary expansion treatment, age between 6 and 10 years old, mixed dentition, good standard of oral hygiene, good compliance during treatment as assessed by the practitioner. Patients will be assigned to one of two expansion methods (arm A: Invisalign® First clear aligners, arm B: to...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients who have been diagnosed with transverse maxillary deficiency;
- • mixed dentition phase with cervical vertebral maturation stage (CVMS) less than 4;
- • fully erupted upper and lower first molars;
- • transversal discrepancy ≤5mm
- • demonstration of a good standard of oral hygiene (determined through questioning and clinical examination);
- • subjects willing to consent to the trial and comply with the trial regime.
- Exclusion Criteria:
- • any general medical health problems which may influence gingival health, such as those necessitating antibiotic cover as bacteremia prophylaxis, diabetes mellitus, epilepsy, or physical or mental disability;
- • permanent teeth extraction-based treatment (third molars excluded);
- • morphologic crown anomalies;
- • auxiliary treatment during arch expansion stage (such as crossbite elastics);
- • posterior interproximal reduction;
- • orthognathic surgery treatment planned;
- • cleft palate or severe facial deformities.
About University Of Turin, Italy
The University of Turin, located in Italy, is a prestigious academic institution renowned for its commitment to research and innovation in the medical field. As a clinical trial sponsor, the university leverages its extensive expertise and resources to advance scientific knowledge and improve patient outcomes. Collaborating with a network of healthcare professionals and researchers, the University of Turin conducts rigorous clinical trials that adhere to the highest ethical and regulatory standards. Its focus on translational research ensures that findings contribute to the development of effective therapies and healthcare solutions, enhancing the overall well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Turin, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials